Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
Volume 301, Issue 5, Pages R1307-R1317
Publisher
American Physiological Society
Online
2011-08-11
DOI
10.1152/ajpregu.00759.2010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy: Implications in Retinal Neovascularization
- (2011) M. Al-Shabrawey et al. DIABETES
- Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease
- (2011) M. A. Saleh et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Examination of Association with Candidate Genes for Diabetic Nephropathy in a Mexican American Population
- (2010) S. Kim et al. Clinical Journal of the American Society of Nephrology
- Increased CYP2J3 Expression Reduces Insulin Resistance in Fructose-Treated Rats and db/db Mice
- (2010) X. Xu et al. DIABETES
- Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice
- (2010) Craig R. Lee et al. FASEB JOURNAL
- Targeting Epoxides for Organ Damage in Hypertension
- (2010) John D Imig JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
- (2010) P. Luo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
- (2009) Jun-Yan Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pathogenic perspectives for the role of inflammation in diabetic nephropathy
- (2009) Antonio Rivero et al. CLINICAL SCIENCE
- Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats
- (2009) Ahmed A. Elmarakby et al. CLINICAL SCIENCE
- Regulation of Soluble Epoxide Hydrolase (sEH) in Mice with Diabetes: High Glucose Suppresses sEH Expression
- (2009) Ami Oguro et al. Drug Metabolism and Pharmacokinetics
- Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice
- (2009) K. Sodhi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Microvascular Complications of Diabetes Mellitus: Renal Protection Accompanies Cardiovascular Protection
- (2008) W. Virgil Brown AMERICAN JOURNAL OF CARDIOLOGY
- Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto–Kakizaki rats
- (2008) Jeffrey J. Olearczyk et al. CLINICAL SCIENCE
- Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity
- (2008) N. Abraham et al. CURRENT PHARMACEUTICAL DESIGN
- TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats
- (2007) Ahmed A. Elmarakby et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started